Good to see this finally happening even though this is all expected.
Frank did alright with Juniper Pharmaceuticals as CEO 2009-2016
https://www.reuters.com/article/us-juniper-pharms-m-a-catalent-idUSKBN1JT0WL
Start date: 08/26/2011 1 End date: 08/14/2018 2 Start price/share: $2.07 3 End price/share: $11.50 4 Dividends collected/share: $0.00 5 Total return: 455.56% 6 Average Annual Total Return: 27.88%
Before that Skyepharma from 2006-2016 ( CEO/Board/Chairman )
https://www.biospace.com/article/releases/skyepharma-plc-makes-senior-appointments-new-ceo-coo-/
Eventually was acquired
https://www.reuters.com/article/us-skyepharma-m-a-vectura-grp-idUSKCN0WI1A9
And Ivax was sold to TEVA before that.
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma board renewal and new Chairman
Ann: Mayne Pharma board renewal and new Chairman, page-8
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$3.99 |
Change
0.020(0.50%) |
Mkt cap ! $339.4M |
Open | High | Low | Value | Volume |
$3.88 | $4.12 | $3.88 | $451.5K | 112.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 420 | $3.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.03 | 420 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 420 | 3.970 |
1 | 420 | 3.960 |
1 | 420 | 3.950 |
1 | 2400 | 3.930 |
2 | 2193 | 3.900 |
Price($) | Vol. | No. |
---|---|---|
4.030 | 420 | 1 |
4.040 | 420 | 1 |
4.050 | 420 | 1 |
4.060 | 1601 | 6 |
4.080 | 3225 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online